• 1
    Ventura HO, Mehra MR. The growing burden of heart failure: the “syndemic” is reaching Latin America. Am Heart J. 2004;147:386389.
  • 2
    El-Menyar A, Zubaid M, Shehab A, et al. Prevalence and impact of cardiovascular risk factors among patients presenting with acute coronary syndrome in the middle East. Clin Cardiol. 2011;34:5158.
  • 3
    Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause, 1990–2020: Global Burden of Disease Study. Lancet. 1997;349:14981504.
  • 4
    Health statistics: main causes of general mortality in Mexico, 2008. Mexico City, Mexico: SINAIS; 2008. Accessed July 24, 2010.
  • 5
    Gaxiola E, Eng-Ceceña L, Ortiz-Galván F, et al.; Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH Registry. Clin Cardiol. 2010;33:445451.
  • 6
    Cantú-Brito C, Chiquete E, Ruiz-Sandoval JL, et al. Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH Registry. Clin Cardiol. 2012;35:451457.
  • 7
    Lanas F, Avezum A, Bautista LE, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115:10671074.
  • 8
    Kabagambe EK, Baylin A, Campos H. Nonfatal acute myocardial infarction in Costa Rica: modifiable risk factors, population-attributable risks, and adherence to dietary guidelines. Circulation. 2007;115:10751081.
  • 9
    Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364:937952.
  • 10
    Fox KA, Eagle KA, Gore JM, et al. The Global Registry of Acute Coronary Events, 1999 to 2009—GRACE. Heart. 2010;96:10951101.
  • 11
    ACCESS Investigators. Management of acute coronary syndromes in developing countries: acute coronary events—a multinational survey of current management strategies. Am Heart J. 2011;162:852859.
  • 12
    Medina HM, Cannon CP, Fonarow GC, et al. Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from Get With The Guidelines-Coronary Artery Disease. Clin Cardiol. 2012;35:632640.
  • 13
    Alpert JS. Are data from clinical registries of any value? Eur Heart J. 2000;21:13991401.
  • 14
    García-Castillo A, Jerjes-Sánchez C, Martínez Bermúdez P, et al. Mexican Registry of Acute Coronary Syndromes. Arch Cardiol Mex. 2005;75(suppl 1):S6S32.
  • 15
    Lupi Herrera E; National Registry of Acute Ischemic Coronary Syndromes (RENASICA). Mexican Cardiology Society. The RENASICA Cooperative Group [article in Spanish]. Arch Cardiol Mex. 2002;72(suppl 2):S45S64.
  • 16
    Juárez-Herrera U, Jerjes-Sánchez C, González-Pacheco H, et al. In-hospital outcome in patients with ST elevation myocardial infarction and right bundle branch block: a sub-study from RENASICA II, a national multicenter registry. Arch Cardiol Mex. 2010;80:154158.
  • 17
    Sánchez-Diaz CJ, García-Badillo E, Sánchez-Ramírez CJ, et al. Clinical characteristics, process of care and outcomes among Mexican, Hispanic and non-Hispanic white patients presenting with non-ST elevation acute coronary syndromes: data from RENASICA and CRUSADE registries. Arch Cardiol Mex. 2012;82:1421.
  • 18
    Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin: the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002;23:11901201.
  • 19
    Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006;27:22852293.
  • 20
    Schamroth C; for ACCESS South Africa Investigators. Management of acute coronary syndrome in South Africa: insights from the ACCESS (Acute Coronary Events—a Multinational Survey of Current Management Strategies) registry. Cardiovasc J Afr. 2012;23:365370.
  • 21
    Conti CR. Is door-to-balloon time the best metric to assess successful treatment of STEMI? Clin Cardiol. 2011;34:408409.
  • 22
    Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000;36:20562063.
  • 23
    Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358363.
  • 24
    Al-Mallah MH, Alsheikh-Ali AA, Almahmeed W, et al. Missed opportunities in the management of ST-segment elevation myocardial infarction in the Arab Middle East: patient and physician impediments. Clin Cardiol. 2010;33:565571.
  • 25
    Xavier D, Pais P, Devereaux PJ, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008;371:14351442.
  • 26
    Villalpando S, Shamah-Levy T, Rojas R, et al. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993–2006. Salud Publica Mex. 2010;52(suppl 1):S72S79.
  • 27
    Cronin EM, Kearney PM, Kearney PP, et al. Impact of a national smoking ban on hospital admission for acute coronary syndromes: a longitudinal study. Clin Cardiol. 2012;35:205209.